Dixon Mitchell Investment Counsel Inc. Novartis Ag Transaction History

Dixon Mitchell Investment Counsel Inc.

  • $2.2 Trillion
  • Q3 2024

Shares

40 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024
BUY
$92.57 - $107.37 $1,481 - $1,717
16 New
16 $1.7 Million
Q3 2021

Jan 17, 2024
SELL
$81.78 - $95.14 $8.44 Million - $9.82 Million
-103,207 Closed
0 $0
Q2 2021

Jan 17, 2024
SELL
$85.24 - $94.15 $9,120 - $10,074
-107 Reduced 0.1%
103,207 $9.42 Billion
Q1 2021

Jan 17, 2024
BUY
$83.5 - $98.47 $1.03 Million - $1.21 Million
12,288 Added 13.5%
103,314 $8.83 Billion
Q4 2020

Jan 17, 2024
SELL
$78.07 - $94.43 $10,305 - $12,464
-132 Reduced 0.14%
91,026 $8.6 Billion
Q3 2020

Jan 17, 2024
BUY
$82.14 - $91.0 $3.38 Million - $3.75 Million
41,200 Added 82.47%
91,158 $7.93 Billion
Q2 2020

Jan 17, 2024
BUY
$80.93 - $91.1 $203,134 - $228,661
2,510 Added 5.29%
49,958 $4.36 Billion
Q1 2020

Jan 17, 2024
SELL
$70.67 - $99.01 $290,665 - $407,228
-4,113 Reduced 7.98%
47,448 $3.91 Billion
Q4 2019

Jan 17, 2024
BUY
$84.35 - $95.37 $89,157 - $100,806
1,057 Added 2.09%
51,561 $4.88 Billion
Q3 2019

Jan 17, 2024
SELL
$85.54 - $94.26 $31,222 - $34,404
-365 Reduced 0.72%
50,504 $4.39 Billion
Q2 2019

Jan 17, 2024
BUY
$75.4 - $92.8 $91,309 - $112,380
1,211 Added 2.44%
50,869 $4.64 Billion
Q1 2019

Jan 17, 2024
SELL
$75.32 - $86.15 $3.84 Million - $4.39 Million
-50,967 Reduced 50.65%
49,658 $4.77 Billion
Q4 2018

Jan 17, 2024
SELL
$73.66 - $82.02 $100,324 - $111,711
-1,362 Reduced 1.34%
100,625 $8.63 Billion
Q3 2018

Jan 17, 2024
BUY
$66.94 - $77.43 $49,937 - $57,762
746 Added 0.74%
101,987 $8.79 Billion
Q2 2018

Jan 17, 2024
BUY
$64.91 - $73.36 $96,001 - $108,499
1,479 Added 1.48%
101,241 $7.65 Billion
Q1 2018

Jan 17, 2024
BUY
$70.39 - $84.15 $261,287 - $312,364
3,712 Added 3.86%
99,762 $8.07 Billion
Q4 2017

Jan 17, 2024
BUY
$72.33 - $77.64 $485,985 - $521,663
6,719 Added 7.52%
96,050 $8.06 Billion
Q3 2017

Jan 17, 2024
SELL
$74.14 - $77.27 $40,999 - $42,730
-553 Reduced 0.62%
89,331 $7.67 Billion
Q2 2017

Jan 17, 2024
BUY
N/A
1,265 Added 1.43%
89,884 $7.5 Billion
Q1 2017

Jan 17, 2024
BUY
N/A
15,252 Added 20.79%
88,619 $6.58 Billion
Q4 2016

Jan 17, 2024
BUY
N/A
3,780 Added 5.43%
73,367 $5.34 Billion
Q3 2016

Jan 17, 2024
BUY
N/A
4,725 Added 7.28%
69,587 $5.49 Billion
Q2 2016

Jan 17, 2024
BUY
N/A
2,317 Added 3.7%
64,862 $5.35 Billion
Q1 2016

Jan 17, 2024
BUY
N/A
851 Added 1.38%
62,545 $4.53 Billion
Q4 2015

Jan 17, 2024
BUY
N/A
3,297 Added 5.65%
61,694 $5.31 Billion
Q3 2015

Jan 17, 2024
BUY
N/A
1,331 Added 2.33%
58,397 $5.37 Billion
Q2 2015

Jan 17, 2024
BUY
N/A
917 Added 1.63%
57,066 $5.61 Billion
Q1 2015

Jan 17, 2024
BUY
N/A
20,940 Added 59.47%
56,149 $5.54 Billion
Q3 2014

Jan 17, 2024
BUY
N/A
752 Added 2.18%
35,209 $3.31 Billion
Q2 2014

Jan 17, 2024
BUY
N/A
1,339 Added 4.04%
34,457 $3.12 Billion
Q1 2014

Jan 17, 2024
BUY
N/A
2,985 Added 9.91%
33,118 $2.82 Billion
Q4 2013

Jan 17, 2024
BUY
N/A
1,841 Added 6.51%
30,133 $2.42 Billion
Q3 2013

Jan 17, 2024
BUY
N/A
5,780 Added 25.68%
28,292 $2.17 Billion
Q2 2013

Jan 17, 2024
BUY
N/A
3,747 Added 19.97%
22,512 $1.59 Billion
Q1 2013

Jan 17, 2024
SELL
N/A
-6,430 Reduced 25.52%
18,765 $1.34 Billion
Q4 2012

Jan 17, 2024
BUY
N/A
620 Added 2.52%
25,195 $1.59 Billion
Q3 2012

Jan 17, 2024
BUY
N/A
1,525 Added 6.62%
24,575 $1.51 Billion
Q2 2012

Jan 17, 2024
BUY
N/A
1,220 Added 5.59%
23,050 $1.29 Billion
Q1 2012

Jan 17, 2024
BUY
N/A
15,310 Added 234.82%
21,830 $1.21 Billion
Q4 2011

Jan 17, 2024
BUY
N/A
6,520
6,520 $373 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Dixon Mitchell Investment Counsel Inc. Portfolio

Follow Dixon Mitchell Investment Counsel Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Mitchell Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dixon Mitchell Investment Counsel Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email